Carl Zeiss Meditec AG Financials

Market Capitalization €4.77 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	30.65
Forward PE	22.33
Price to Sales TTM	€2.20
Price to Book MRQ	€2.28
Enterprise to Revenue	2.57
Enterprise to EBITDA	23.60

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-09-30
Most Recent Quarter	2025-03-31
Profit Margin	7.19%
Operating Margin	12.71%
Return on Assets TTM	3.48%
Return on Equity TTM	7.47%

Income Statement

Revenue TTM	€2,169,434,112
Revenue per Share TTM	€24.68
Quarterly Revenue Growth	18.60%
Gross Profit TTM	€1,137,401,984
EBITDA	€216,165,000
Net Income to Common TTM	€155,880,992
Diluted EPS TTM	€1.77
Quarterly Earnings Growth YoY	-2.50%

Balance Sheet

Total Cash MRQ	€26,550,000
Total Cash per Share MRQ	€0.31
Total Debt MRQ	€
Total Debt to Equity MRQ	28.46
Current Ratio MRQ	2.04
Book Value per Share MRQ	€23.81

Cash Flow

Operating Cash Flow TTM	€195,606,000
Levered Free Cash Flow TTM	€756,107,264

AFX Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	87,536,079
Float Shares	34,489,917
Avg 10 Volume	128
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.14%
% Held by Institutions	21.60%

Stock Price Summary

Beta	1.23
Fifty Two Week Low	€44.44
Fifty Two Week High	€71.65
Fifty Two Week Change	-21.28%
Day 50 MA	€59.19
Day 200 MA	€57.68

Dividends and Splits

Forward Annual Dividend Rate	€2.40
Forward Annual Dividend Yield	4.44%
Trailing Annual Dividend Rate	€0.60
Trailing Annual Dividend Yield	1.11%
Payout Ratio	33.90%
Dividend Date
Ex Dividend Date	2025-03-27
Last Split Factor
Last Split Date